Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Urol Int ; 68(4): 251-4, 2002.
Article in English | MEDLINE | ID: mdl-12053027

ABSTRACT

INTRODUCTION: The chemical stability of prostaglandin E(1) (PGE(1)) in physiological solution has been studied in different environmental conditions. However, very little data exist regarding the PGE(1) stability and the consequent breakdown products in PGE(1)-based vasoactive cocktails under different environmental conditions. OBJECTIVE: To evaluate the loss of the therapeutic efficacy of PGE(1) either alone or in combination with other vasoactive substances under different storage conditions. MATERIALS AND METHODS: Utilizing high performance liquid chromatography the PGE(1) content was evaluated alone and in association with papaverine and papaverine plus phentolamine at temperatures of 2-8 and at 20 degrees C, and after 15, 30, 60, 90 and 120 days of storage using multivariate statistical analysis of variance. RESULTS: We found that the time of storage significantly affects PGE(1) activity. Furthermore, both the storage temperature and cocktail composition had a significant effect on PGE(1) stability. The chromatographic studies did not disclose the presence of the principal degradation products of PGE(1) (PGA(1), PGB(1)). The presence of papaverine and temperature of 20 degrees C have the greatest effect on the degradation of PGE(1 )during the first 30 days of storage. DISCUSSION: Temperature and time are prevalent factors determining the slow and progressive deterioration curve of PGE(1) after 30 days of storage. None of the environmental conditions evaluated was so drastic to determine the presence of PGA(1) and PGB(1). CONCLUSION: For clinical use, one should note that PGE(1) maintains 50-80% of its efficacy for about 1 month even if stored at room temperature (20 degrees C) and/or combined with papaverine.


Subject(s)
Alprostadil/pharmacokinetics , Vasodilator Agents/pharmacokinetics , Alprostadil/therapeutic use , Drug Stability , Drug Therapy, Combination , Erectile Dysfunction/drug therapy , Humans , Male , Temperature , Vasodilator Agents/therapeutic use
2.
Urol Int ; 65(3): 155-9, 2000.
Article in English | MEDLINE | ID: mdl-11054034

ABSTRACT

INTRODUCTION: Italy delayed limiting access to the Faculty of Medicine and the reform of schools of specialization was not accompanied by programming the number of scholarships, so employment expectations are often disappointing. The aim of this study is to analyze the employment prospects of specialists in urology through the development of possible scenarios for the 5-year period 2000-2004. MATERIALS AND METHODS: We recorded data received from Italian Schools of Specialization in Urology on specialists in the 5-year period 1994-1998. We also tried to obtain a picture of the national distribution of urologists and urological units. Statistical processing was done with SPSS for Windows 5.0. RESULTS: In the last 5 years, 501 urologists were licensed at an average age of 37 years; 535 urological units exist; 2,332 doctors practice urology (2,235 males and 97 females) for a ratio of 1 urologist to 24,500 inhabitants. By comparing the 'entrance' forecast with the potential 'exit', we can hypothesize an annual excess of 80 units. There is no significant correlation between the number of urologists in each structure and the number of inhabitants for each urologist. CONCLUSIONS: The present government programme does not take into account continual changes in employment and many other variables when defining the actual need for specialists. For valid predictions, the data we obtain must be updated for at least 5 years.


Subject(s)
Urology , Adult , Employment/statistics & numerical data , Employment/trends , Female , Forecasting , Humans , Italy , Male , Middle Aged , Urology/trends , Urology Department, Hospital/statistics & numerical data , Workforce
3.
J Urol ; 160(2): 551-5, 1998 Aug.
Article in English | MEDLINE | ID: mdl-9679927

ABSTRACT

PURPOSE: Vasoactive cocktails are widely used in diagnosing and treating erectile dysfunction, especially in poor responders to prostaglandin E1 (PGE1). However, very little information as to their chemical interactions and stability is available, despite the huge amount of published work regarding their clinical efficacy. Obviously, medical and legal problems are involved. MATERIALS AND METHODS: We analyzed four kinds of vasoactive cocktails, composed of papaverine, phentolamine and PGE1 in different combinations, using High Performance Liquid Chromatography analysis after 5 to 60 days of storage at temperatures between 2 and 8C. SPSS MANOVA analysis and a t-test for paired samples were used for statistical purposes. RESULTS: Papaverine and phentolamine concentrations showed no significant variations during the 2 month study, ranging from a minimum of 96.75+/-1.20 to a maximum of 103.00+/-0.20% of the starting values. In the same period, PGE1 showed an accelerated degradation profile, reaching concentration values, after 60 days, of 76.00+/-2.28% and 70.20+/-2.02% when added to phentolamine or papaverine respectively and 70.00+/-2.40% with both. CONCLUSIONS: Papaverine and phentolamine are characterized by chemical stability when blended together or with PGE1. Papaverine and/or phentolamine increase the naturally occurring degradation of PGE1 in physiological solution. This effect is most evident in the first 10 days. Papaverine has the greatest deteriorating effect on PGE1. A safe and proper use of these cocktails should take into account the variations of PGE1 concentration.


Subject(s)
Adrenergic alpha-Antagonists/chemistry , Alprostadil/chemistry , Papaverine/chemistry , Phentolamine/chemistry , Vasodilator Agents/chemistry , Adrenergic alpha-Antagonists/administration & dosage , Alprostadil/administration & dosage , Chromatography, High Pressure Liquid , Drug Combinations , Drug Interactions , Drug Stability , Drug Storage , Erectile Dysfunction/diagnosis , Erectile Dysfunction/drug therapy , Humans , Male , Multivariate Analysis , Papaverine/administration & dosage , Phentolamine/administration & dosage , Time Factors , Vasodilator Agents/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL
...